A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
NCT02693990 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2026-04-15
Summary
This research study is studying radiation therapy as a possible treatment for meningioma or tumor on the lining of the brain. The study drug or intervention involved in this research study is Intensity Modulated Proton Therapy (IMPT)
Conditions
- Meningioma
- Brain Tumor
Interventions
- RADIATION
-
Intensity Modulated Proton Therapy (IMPT)
Radiation Therapy - Intensity Modulated Proton Therapy (IMPT)
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Helen A Shih, MD · Massachusetts General Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- United States
Study Locations
More Related Trials
-
Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases
NCT00328575 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
NCT00626730 ·Status: UNKNOWN ·Phase: PHASE2
-
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
NCT05393258 ·Status: COMPLETED ·Phase: NA
-
Whole Brain Radiation Using IMRT for Patients With Brain Metastases
NCT02753790 ·Status: COMPLETED ·Phase: NA
-
Temozolomide and Radiation Therapy in Treating Patients With Gliomas
NCT00114140 ·Status: COMPLETED ·Phase: PHASE2
-
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas
NCT00033280 ·Status: COMPLETED ·Phase: PHASE2
-
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas
NCT01024907 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
NCT01288235 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Hypofractionated Radiation Therapy for Glioblastoma
NCT02206230 ·Status: COMPLETED ·Phase: PHASE2
-
Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
NCT00074607 ·Status: TERMINATED ·Phase: PHASE1
-
Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
NCT00068250 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
NCT03286335 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
NCT03550391 ·Status: RECRUITING ·Phase: PHASE3
-
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
NCT00019578 ·Status: COMPLETED ·Phase: PHASE1
-
Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma
NCT01063114 ·Status: COMPLETED ·Phase: NA
-
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
NCT04396860 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases
NCT01592968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT00099125 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
NCT00492687 ·Status: UNKNOWN ·Phase: PHASE2
-
Proton Radiation Therapy for Gliomas
NCT01358058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
NCT01062425 ·Status: COMPLETED ·Phase: PHASE2
-
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
NCT00662506 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
NCT01119599 ·Status: COMPLETED ·Phase: PHASE1
-
Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas
NCT02978677 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Radiation Therapy in Treating Patients With Glioblastoma
NCT00019058 ·Status: COMPLETED ·Phase: PHASE1